Back to Results
First PageMeta Content
Protein kinase inhibitors / Tyrosine kinases / Immunosuppressants / Lenalidomide / Orphan drugs / CD135 / Multiple myeloma / Targeted therapy / Aurora inhibitor / Biology / Chemistry / Cell biology


Encouraging Data on Astex’s Anti-Cancer Drug AT9283 to be Presented at ASH New Data Suggest a Potential Role for AT9283 in Combination With Lenalidomide and With Docetaxel in the Treatment of Multiple Myeloma and Non-H
Add to Reading List

Open Document

File Size: 23,10 KB

Share Result on Facebook
UPDATE